Articles
 

The Persian Version of the Chronic Urticaria Quality of Life Questionnaire: Factor Analysis, Validation, and Initial Clinical Findings

Abstract

Chronic urticaria (CU) also known as chronic idiopathic urticaria results in a lowered quality of life (QoL). Disease specific questionnaires are necessary to assess QoL in CU patients. Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) is the only available and validated disease specific questionnaire in the assessment of QoL in CU patients originally developed in Italian language. The aim of the current study was to develop the Persian version of the CU-Q2oL with an acceptable reliability and validity.
Using the standard methods provided by guidelines, CU-Q2oL was translated into Persian. A total number of 110 patients with confirmed diagnosis of CU were asked to fill the questionnaire. Determination of scales was performed in addition to checking the data for internal consistency and known group validity. Urticaria activity score 7 (UAS-7) was used to assess the severity of the CU in the population study. The 6 dimensional scale of Persian CU-Q2oL was determined using the Exploratory Factor Analysis. About 68% of the variance was explained by these 6 factor structure higher than 59.9% of the original Italian version.
All 6 factors showed acceptable internal consistency as measured by Cronbach α coefficient. There was a  significant  correlation  between  UAS-7  and  total  CU-Q2oL  score.  UAS7  and  the  presence  of angioedema were predictors of CU-Q2oL score.
The Persian version of CU-Q2oL was shown to be a valid and reliable tool to be used in the future clinical studies. Cultural considerations must be kept in mind in adoption of CU-Q2oL to other languages.

1. Greaves M. Chronic urticaria. J Allergy Clin Immunol 2000; 105(4):664-72.

2. Gaig P, Olona M, Muñoz Lejarazu D, Caballero MT, Domínguez FJ, Echechipia S, et al. Epidemiology of urticaria in Spain. J Investig Allergol Clin Immunol 2004;14(3):214-20.

3. Valero A, Herdman M, Bartra J, Ferrer M, Jáuregui I, Dávila I, et al. Adaptation and validation of the Spanish version of the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL). J Investig Allergol Clin Immunol 2008; 18(6):426-32.

4. Uguz F, Engin B, Yilmaz E. Quality of life in patients with chronic idiopathic urticaria: the impact of Axis I and Axis II psychiatric disorders. Gen Hosp Psychiatry 2008;30(5):453-7.

5. Yun J, Katelaris CH, Weerasinghe A, Adikari DB, Ratnayake C. Impact of chronic urticaria on the quality of life in Australian and Sri Lankan populations. Asia Pac Allergy 2011; 1(1):25-9.

6. Młynek A, Magerl M, Hanna M, Lhachimi S, Baiardini I, Canonica GW, et al. The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings. Allergy 2009;64(6):927-36.

7. Hyland ME. A brief guide to the selection of quality of life instrument. Health Qual Life Outcomes 2003; 1:24.

8. O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136(2):197-201.

9. Baiardini I, Pasquali M, Braido F, et al. A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Allergy 2005; 60(8):1073-8.

10. Kocatürk E, Weller K, Martus P, Aktas S, Kavala M, Sarigul S et al. Turkish version of the chronic urticaria quality of life questionnaire: cultural adaptation, assessment of reliability and validity. Acta Derm Venereol 2012; 92(4):419-25.

11. Brzoza Z, Badura-Brzoza K, Młynek A, Magerl M, Baiardini I, Canonica GW, et al. Adaptation and initial results of the Polish version of the GA(2)LEN chronic urticaria quality of life questionnaire (CU-Q(2)oL). J Dermatol Sci 2011; 62(1):36-41.

12. Dias GA, Pires GV, Valle SO, França AT, Papi JA, Dortas SD Jr, et al. Cross-cultural adaptation of the Brazilian-Portuguese version of the chronic urticaria quality-of-life questionnaire - CU-Q2oL. Allergy 2011;66(11):1487-93.

13. Baiardini I, Braido F, Bindslev-Jensen C, Bousquet PJ, Brzoza Z, Canonica GW, et al. Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. Allergy 2011; 66(7):840-4.

14. Młynek A, Zalewska-Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M. How to assess disease activity in patients with chronic urticaria? Allergy 2008; 63(6):777-80.

15. Kang MJ, Kim HS, Kim HO, Park YM. The impact of chronic idiopathic urticaria on quality of life in korean patients. Ann Dermatol 2009; 21(3):226-9.

16. Kim H, Lynde C. Impact of Desloratadine on Symptoms and Quality of Life in Subjects with Chronic Idiopathic Urticaria: A Multicenter, Practice-based Study. ArchDrug Inf 2008; 1(2):63-9.

Files
IssueVol 13, No 4 (2014) QRcode
SectionArticles
 
Keywords
Adaptation Chronic urticaria Persian Quality of life Questionnaire Validation

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Tavakol M, Mohammadinejad P, Baiardini I, Braido F, Gharagozlou M, Aghamohammadi A, Nabavi M, Dabbaghzade A, Tavakol Z, Afarideh M, Rezaei N, Movahedi M. The Persian Version of the Chronic Urticaria Quality of Life Questionnaire: Factor Analysis, Validation, and Initial Clinical Findings. Iran J Allergy Asthma Immunol. 1;13(4):278-285.